This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set ...
By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...
Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid ...
Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s ...
3d
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the ...
Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s ...
3don MSN
US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results